Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **zinc-activated ligand-gated ion channel (ZACN)** is a member of the Cys-loop receptor superfamily, which encompasses pentameric ligand-gated ion channels such as nicotinic acetylcholine, 5-HT3, GABA_A, and glycine receptors[1][4]. ZACN forms a cation-selective ion channel that is gated primarily by Zn^2+, but also by Cu^2+ and H^+, and is non-selectively permeable to monovalent cations such as Na^+, K^+, and Cs^+[1][4]. In contrast to other Cys-loop receptors, ZACN is *not* permeable to divalent cations like Ca^2+ and Mg^2+; these ions instead inhibit the channel[1]. ZACN is broadly expressed in human tissues, including the brain, spinal cord, and various peripheral organs, but is absent from rodent genomes[4]. Because its agonist, Zn^2+, is a key modulator in the nervous system, ZACN has been proposed to serve as a Zn^2+ sensor and may play a role in metal ion homeostasis and signal transduction[2][3]. Structural and functional data suggest ZACN's unique properties distinguish it from better-known Cys-loop receptors, though its precise physiological and pathological significance remains under study[2][3][1]. There are currently no approved drugs targeting ZACN, and its full disease association and biomarker relevance have not been established.
Channel agonism (by Zn^2+, Cu^2+, H^+), channel inhibition (by Ca^2+, Mg^2+)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc-activated ligand-gated ion channel (ZACN).